Characteristics, consent patterns, and challenges of randomized trials using the Trials within Cohorts (TwiCs) design - A scoping review

2024-10-1

A brief note on the random-effects meta-analysis model and its relationship to other models

2024-10-1

The evidence base of the 10 most prescribed drugs in England, France, and the United States: a scoping review

2024-10-1

Sample size in multistakeholder Delphi surveys: at what minimum sample size do replicability of results stabilise?

2024-10-1

The Flare-OA-16 questionnaire measuring flare in knee and hip osteoarthritis in the patient perspective: scale reduction and validation using a Rasch model

2024-10-1

Commentary: core descriptor sets using consensus methods support ‘table one’ consistency

2024-10-1

Comments, Suggestions and Criticisms of the PRECIS-2 Design Tool: A Citation Analysis

2024-9-1

Benchmarking Human-AI Collaboration for Common Evidence Appraisal Tools

2024-9-1

A review of core outcome sets (COS) developed for different settings finds there is a subset of outcomes relevant for both research and routine care

2024-9-1

A machine learning model for early diagnosis of type 1 Gaucher disease using real-life data

2024-9-1

Item response theory validation of the Oxford Knee Score and Activity and Participation Questionnaire: a step towards a common metric

2024-9-1

Harmonisation of data collection to improve clinical and public health evidence-based decision making.

2024-9-1

Data quality assessment of interventional trials in public trial databases

2024-9-1

Analyses of academician cohorts generate biased pandemic excess death estimates

2024-9-1

Statistical Analysis of Self-Reported Health Conditions in Cohort Studies: Handling of Missing Onset Age

2024-9-1

Identification of Retracted Publications and Completeness of Retraction Notices in Public Health

2024-9-1

Required knowledge for guideline panel members to develop healthcare related testing recommendations – a developmental study

2024-9-1

A systematic survey of 200 systematic reviews with network meta-analysis (published 2020–2021) reveals that few reviews report structured evidence summaries

2024-9-1

Evaluation of adherence to STARD for abstracts in a diverse sample of diagnostic accuracy abstracts published in 2012 and 2019 reveals suboptimal reporting practices

2024-9-1

Intention to treat and per protocol analyses: differences and similarities

2024-9-1

Incorporating postmenopausal women's perspectives into osteoporosis clinical guidelines: A systematic review

2024-9-1

Two assumptions of the prior event rate ratio approach for controlling confounding can be evaluated by self-controlled case series and dynamic random intercept modelling

2024-9-1

Implementation of a dynamic model updating pipeline provides a systematic process for maintaining performance of prediction models

2024-9-1

Panel stacking is a threat to consensus statement validity

2024-9-1

Mapping the awareness and knowledge about patient and public versions of guidelines among stakeholders in China: a cross-sectional survey

2024-9-1

Key concepts in rapid reviews: an overview

2024-9-1

Promoting Equity, Diversity, and Inclusion in Surveys: Insights from a Patient-engaged Study to Assess Long COVID Healthcare Needs in Brazil

2024-9-1

The association of social vulnerability index and trial of labor after cesarean

2024-9-1

Substantial discrepancies exist between registered protocol and published manuscript in trials on exercise interventions for chronic low back pain: a metaresearch study

2024-9-1

Indirect effects in mediation analyses should still include measures of uncertainty and when appropriate, test for statistical significance

2024-8-1

Avoiding double counting: the effect of bundling hospital events in administrative datasets for the interpretation of rural-urban differences in Aotearoa New Zealand

2024-8-1

Indirect effects in mediation analyses should still include measures of uncertainty and when appropriate, test for statistical significance: Author reply

2024-8-1

Effect of screening mammography on the risk of breast cancer death and of all-cause death: A systematic review with meta-analysis of cohort studies

2024-8-1

Long-term statin use and risk of cancers: a target trial emulation study

2024-8-1

Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial

2024-8-1

Adherence to PRISMA-A and reporting was suboptimal in meta-analysis abstracts on drug efficacy for tumors: a literature survey

2024-8-1

Surrogate endpoint meta-regression: Useful statistics for regulators and trialists

2024-8-1

Journal requirement for data sharing statements in clinical trials: a cross-sectional study

2024-8-1

Identification of homelessness using health administrative data in Ontario, Canada following a national coding mandate: a validation study

2024-8-1

Physicians found an interactive tool displaying structured evidence summaries for multiple comparisons understandable and useful: A qualitative user-testing study

2024-8-1

Corrigendum to “P value–driven methods were underpowered to detect publication bias: analysis of Cochrane review meta-analyses”, Journal of Clinical Epidemiology, volume 118, (2020), 86-92.

2024-8-1

Don't be misled: 3 misconceptions about external validation of clinical prediction models

2024-8-1

What should journals do to prevent the publication of methodologically flawed systematic reviews?

2024-8-1

Editorial Board

2024-8-1

Table of Contents

2024-8-1

A survey of experts to identify methods to detect problematic studies: Stage 1 of the INSPECT-SR Project

2024-8-1

Barriers and opportunities faced by public health practitioners in using public health guidance on COVID-19: a knowledge translation exercise for the eCOVID-19 RecMap

2024-8-1

Long list of conflicts of interest in industry-funded drug trials are counterproductive and opaque for readers

2024-8-1

Stakeholder-informed positivity thresholds for disease markers and risk scores: a methodological framework and an application in obstructive lung disease

2024-8-1

A scoping review shows that no single existing risk of bias assessment tool considers all sources of bias for cross-sectional studies

2024-8-1